tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Donald Ellis, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).
Analyst Donald Ellis, carries an average stock price target met ratio of 57.42% that have a potential upside of 60.1% achieved within 532 days. Previously, Donald Ellis worked at JMP.
Donald Ellis’s has documented 75 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on CLS, Celestica at 21-Dec-2021.
Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%) receiving and performance score of 15.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Nov-2024
$4
$0.72 (21.95%)
$3
5 months 15 days ago
(08-May-2026)
4/5 (80%)
$-0.93 (-18.86%)
50
Buy Since 05-May-2026
$11
$7.72 (235.37%)
$6
5 months 18 days ago
(05-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 29-Nov-2016
$12
$8.72 (265.85%)
5 months 18 days ago
(05-May-2026)
0/2 (0%)
$7.25 (152.63%)
Buy Since 28-May-2025
$10
$6.72 (204.88%)
$8
5 months 24 days ago
(29-Apr-2026)
0/3 (0%)
$5.53 (123.71%)
Buy Since 14-May-2025
$16
$12.72 (387.80%)
$16
6 months 8 days ago
(15-Apr-2026)
0/10 (0%)
$12.07 (307.12%)
